References
- Foley RN, Collins AJ. End-stage renal disease in the United States: An update from the united states renal data system. J Am Soc Nephrol 2007;18:2644-8. https://doi.org/10.1681/ASN.2007020220
- Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 2000;11:319-29.
- Antus B, Yao Y, Song E, Liu S, Lutz J, Heemann U. Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl Int 2002;15:494-501. https://doi.org/10.1111/j.1432-2277.2002.tb00205.x
- Baltatu O, Cayla C, Iliescu R, Andreev D, Jordan C, Bader M. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J Am Soc Nephrol 2002;13:2681-7. https://doi.org/10.1097/01.ASN.0000033327.65390.CA
- Reckelhoff JF, Zhang H, Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats: Role of the renin-angiotensin system. Hypertension 2000;35:480-3. https://doi.org/10.1161/01.HYP.35.1.480
- Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem 2004;279:52282-92. https://doi.org/10.1074/jbc.M407629200
- Nielsen CB, Flyvbjerg A, Bruun JM, Forman A, Wogensen L, Thomsen K. Decreases in renal functional reserve and proximal tubular fluid output in conscious oophorectomized rats: Normalization with sex hormone substitution. J Am Soc Nephrol 2003;14:3102-10. https://doi.org/10.1097/01.ASN.0000096262.18679.25
- Kwan G, Neugarten J, Sherman M, Ding Q, Fotadar U, Lei J, et al. Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int 1996;50:1173-9. https://doi.org/10.1038/ki.1996.425
- Maric C, Sandberg K, Hinojosa-Laborde C. Glomerulosclerosis and tubulointerstitial fibrosis are attenuated with 17beta-estradiol in the aging dahl salt sensitive rat. J Am Soc Nephrol 2004;15:1546-56. https://doi.org/10.1097/01.ASN.0000128219.65330.EA
- Catanuto P, Doublier S, Lupia E, Fornoni A, Berho M, Karl M, et al. 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int 2009;75:1194-201. https://doi.org/10.1038/ki.2009.69
- Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002;283:F861-75.
- Zecher M, Guichard C, Velasquez MJ, Figueroa G, Rodrigo R. Implications of oxidative stress in the pathophysiology of obstructive uropathy. Urol Res 2009;37:19-26. https://doi.org/10.1007/s00240-008-0163-3
- Klahr S. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 1991;18:689-99.
- Chevalier RL. Pathogenesis of renal injury in obstructive uropathy. Curr Opin Pediatr 2006;18:153-60. https://doi.org/10.1097/01.mop.0000193287.56528.a4
- McGuire BB, Watson RW, Perez-Barriocanal F, Fitzpatrick JM, Docherty NG. Gender differences in the renin-angiotensin and nitric oxide systems: Relevance in the normal and diseased kidney. Kidney Blood Press Res 2007;30:67-80. https://doi.org/10.1159/000099150
- Yayama K, Okamoto H. Angiotensin II-induced vasodilation via type 2 receptor: Role of bradykinin and nitric oxide. Int Immunopharmacol 2008;8:312-8. https://doi.org/10.1016/j.intimp.2007.06.012
- Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res 1998;83:1182-91. https://doi.org/10.1161/01.RES.83.12.1182
- Viswanathan M, Tsutsumi K, Correa FM, Saavedra JM. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 1991;179:1361-7. https://doi.org/10.1016/0006-291X(91)91723-P
- Batenburg WW, Garrelds IM, Bernasconi CC, Juillerat-Jeanneret L, van Kats JP, Saxena PR, et al. Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 2004;109:2296-301. https://doi.org/10.1161/01.CIR.0000128696.12245.57
- Wenzel UO, Krebs C, Benndorf R. The angiotensin II type 2 receptor in renal disease. J Renin Angiotensin Aldosterone Syst 2010;11:37-41. https://doi.org/10.1177/1470320309347787
- Mount PF, Power DA. Nitric oxide in the kidney: Functions and regulation of synthesis. Acta Physiol (Oxf) 2006;187:433-46. https://doi.org/10.1111/j.1748-1716.2006.01582.x
- Morrissey JJ, Ishidoya S, McCracken R, Klahr S. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 1996;7:2202-12.
- Miyajima A, Chen J, Kirman I, Poppas DP, Darracott Vaughan EJ, Felsen D. Interaction of nitric oxide and transforming growth factor-beta1 induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urol 2000;164:1729-34. https://doi.org/10.1016/S0022-5347(05)67097-8
- Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1999;1411:217-30. https://doi.org/10.1016/S0005-2728(99)00016-X
- Kosaka H, Yoneyama H, Zhang L, Fujii S, Yamamoto A, Igarashi J. Induction of lox-1 and inos expressions by ischemia-reperfusion of rat kidney and the opposing effect of l-arginine. Faseb J 2003;17:636-43. https://doi.org/10.1096/fj.02-0585com
- Park KM, Byun JY, Kramers C, Kim JI, Huang PL, Bonventre JV. Inducible nitric-oxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney. J Biol Chem 2003;278:27256-66. https://doi.org/10.1074/jbc.M301778200
- Mohaupt MG, Elzie JL, Ahn KY, Clapp WL, Wilcox CS, Kone BC. Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney. Kidney Int 1994;46:653-65. https://doi.org/10.1038/ki.1994.318
- Morrissey JJ, McCracken R, Kaneto H, Vehaskari M, Montani D, Klahr S. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 1994;45:998-1005. https://doi.org/10.1038/ki.1994.135
- Park KM, Kramers C, Vayssier-Taussat M, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury, mapk and mapk kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 2002;277:2040-9. https://doi.org/10.1074/jbc.M107525200
- Gabbiani G. The biology of the myofibroblast. Kidney Int 1992;41:530-2. https://doi.org/10.1038/ki.1992.75
- Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993;122:103-11. https://doi.org/10.1083/jcb.122.1.103
- Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury and jnk, p38, and mapk kinase activation by remote ischemic pretreatment. J Biol Chem 2001;276:11870-6. https://doi.org/10.1074/jbc.M007518200
- Kim J, Kil IS, Seok YM, Yang ES, Kim DK, Lim DG, et al. Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice. A role for manganese superoxide dismutase. J Biol Chem 2006;281:20349-56. https://doi.org/10.1074/jbc.M512740200
- Metcalfe PD, Leslie JA, Campbell MT, Meldrum DR, Hile KL, Meldrum KK. Testosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signaling. Am J Physiol Endocrinol Metab 2008;294:E435-43.
- Mankhey RW, Bhatti F, Maric C. 17beta-estradiol replacement improves renal function and pathology associated with diabetic nephropathy. Am J Physiol Renal Physiol 2005;288:F399-405.
- Dubey RK, Gillespie DG, Keller PJ, Imthurn B, Zacharia LC, Jackson EK. Role of methoxyestradiols in the growth inhibitory effects of estradiol on human glomerular mesangial cells. Hypertension 2002;39:418-24. https://doi.org/10.1161/hy0202.103297
- Matsuda T, Yamamoto T, Muraguchi A, Saatcioglu F. Cross-talk between transforming growth factor-beta and estrogen receptor signaling through smad3. J Biol Chem 2001;276:42908-14. https://doi.org/10.1074/jbc.M105316200
- Niimura F, Kon V, Ichikawa I. The renin-angiotensin system in the development of the congenital anomalies of the kidney and urinary tract. Curr Opin Pediatr 2006;18:161-6. https://doi.org/10.1097/01.mop.0000193288.56528.40
- Siragy HM, Xue C, Abadir P, Carey RM. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation. Hypertension 2005;45:133-7.
- Silva-Antonialli MM, Tostes RC, Fernandes L, Fior-Chadi DR, Akamine EH, Carvalho MH, et al. A lower ratio of AT1/AT2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats. Cardiovasc Res 2004;62:587-93. https://doi.org/10.1016/j.cardiores.2004.01.020
- Gross V, Schunck WH, Honeck H, Milia AF, Kargel E, Walther T, et al. Inhibition of pressure natriuresis in mice lacking the AT2 receptor. Kidney Int 2000;57:191-202. https://doi.org/10.1046/j.1523-1755.2000.00820.x
- Benndorf RA, Krebs C, Hirsch-Hoffmann B, Schwedhelm E, Cieslar G, Schmidt-Haupt R, et al. Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice. Kidney Int 2009;75:1039-49. https://doi.org/10.1038/ki.2009.2
- Ma J, Nishimura H, Fogo A, Kon V, Inagami T, Ichikawa I. Accelerated fibrosis and collagen deposition develop in the renal inter-stitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 1998;53:937-44.
- Armando I, Jezova M, Juorio AV, Terron JA, Falcon-Neri A, Semino-Mora C, et al. Estrogen upregulates renal angiotensin II AT(2) receptors. Am J Physiol Renal Physiol 2002;283:F934-43.
- Gabbai FB, Blantz RC. Role of nitric oxide in renal hemodynamics. Semin Nephrol 1999;19:242-50.
- Valles PG, Pascual L, Manucha W, Carrizo L, Ruttler M. Role of endogenous nitric oxide in unilateral ureteropelvic junction obstruction in children. Kidney Int 2003;63:1104-15. https://doi.org/10.1046/j.1523-1755.2003.00833.x
- Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, et al. Estrogen induces the akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 2001;276:3459-67. https://doi.org/10.1074/jbc.M005036200
- Neugarten J, Ding Q, Friedman A, Lei J, Silbiger S. Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol 1997;8:1240-6.
- Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 2002;61:862-71. https://doi.org/10.1046/j.1523-1755.2002.00234.x
- Yoo KH, Thornhill BA, Forbes MS, Chevalier RL. Inducible nitric oxide synthase modulates hydronephrosis following partial or complete unilateral ureteral obstruction in the neonatal mouse. Am J Physiol Renal Physiol 2010;298:F62-71. https://doi.org/10.1152/ajprenal.00234.2009
- Carey RM, Jin X, Wang Z, Siragy HM. Nitric oxide: A physiological mediator of the type 2 (AT2) angiotensin receptor. Acta Physiol Scand 2000;168:65-71. https://doi.org/10.1046/j.1365-201x.2000.00660.x
- Palm F, Connors SG, Mendonca M, Welch WJ, Wilcox CS. Angiotensin II type 2 receptors and nitric oxide sustain oxygenation in the clipped kidney of early goldblatt hypertensive rats. Hypertension 2008;51:345-51. https://doi.org/10.1161/HYPERTENSIONAHA.107.097832